Answers are grounded in this paper and cite their sources.
Demonstrates synergistic antibacterial effects in MRSA wound infections, suggesting a novel therapeutic approach.
Chronic wound infections caused by methicillin-resistant Staphylococcus aureus (MRSA) often refractory to conventional therapies due to bacterial drug resistance and biofilm formation. To address this challenge, we developed a synergistic antibacterial nanoarchitectonics integrating bacteriophages and quantum dots (QDs-Phage). This system was constructed by bioconjugating MRSA-specific bacteriophage with highly photothermally efficient PbS quantum dots, creating an intelligent therapeutic platform that operates on a "target-first, activate-later" principle. Under near-infrared laser irradiation, the nanoarchitectonics exhibited significant synergistic bactericidal activity against both MRSA and its biofilms in vitro. In a murine model of full-thickness skin wounds infected with MRSA, topical application of QDs-Phage combined with light irradiation significantly accelerated wound closure and promoted tissue repair, without inducing obvious systemic toxicity. This study provides a novel strategy for developing localized antibacterial approaches that combine precise targeting with efficient physical bactericidal functions.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: